Adjuvant Therapy Using Dabrafenib plus Trametinib in Chinese Patients with Resected Stage III Melanoma: A Multicenter Retrospective Cohort Study

Figure 1

Kaplan–Meier curves of relapse-free survival melanoma patients treated with adjuvant dabrafenib plus trametinib.